William Hawkins, M.D., FACS Research Laboratory

William Hawkins, M.D., FACS is a surgical oncologist and researcher focusing on improving outcomes for pancreatic cancer patients. Before joining the Hollings Cancer Center, he was a member of the Senior Leadership for the Alvin J. Siteman Cancer Center, where he co-chaired their cancer center’s research investment program. As the newly appointed Deputy Director at Hollings, Dr. Hawkins aims to promulgate collaborative team science and multi-disciplinary exchanges on a larger scale with the goal of improving detection, treatment, and survival from cancer here in South Carolina.

As a clinician who cares for patients with pancreatic cancer, the dire need for a novel therapeutic approach is painfully evident. Dr. Hawkins will continue his research on novel therapies for the treatment of pancreatic cancer. He will also continue to serve as a Co-Director of the Washington University of Saint Louis Specialized Programs of Research Excellence (SPORE) Team in Pancreatic Cancer. He is expanding the team of clinicians and researchers to address this urgent need by through collaborations with MUSC faculty. Their work is crucial in improving the outcomes for patients with pancreatic cancer through discovery, resource building, and innovation. The Washington University Pancreatic Cancer SPORE, is one of only three pancreatic cancer SPORES in the nation. Continuing this research program helps put MUSC at the forefront of this battle. It is a step towards a more hopeful future in the fight against this disease.

His personal research focuses on systematically developing and testing novel strategies for treating pancreatic adenocarcinoma. Learn more about Dr. Hawkins's personal research.

Dr. Hawkins will continue to see patients with solid malignancies. For his clinical profile please see his clinical webpage.

Hawkins Lab Personnel